DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Positive impactCompany

Lupin Limited — Press Release

NSE 3 hrs ago·10 Aug 2026, 12:29 pm

Lupin

Lupin has announced that the USFDA has approved its Sodium Zirconium Cyclosilicate oral suspension. This medication is used to treat high blood potassium levels in adults.

This approval is significant for Lupin, as it expands its portfolio of generic products in the US market. It allows the company to offer a new treatment option for patients, potentially increasing its market share and revenue streams.

Investors should monitor the launch timeline and market reception of this new product. The success of this launch will be a key factor in determining its impact on Lupin's future financial performance.

Affected stocks

Bullish1 stock

Lupin

LUPIN Bullish

₹2,363.50

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

Concerns Lupin (LUPIN).
Category: Company.
AI reads the tone as positive (potentially bullish) for the stock.

Why it matters

A routine update for Lupin. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NSE.